|
Patent landscape, scope, and claims: |
Scope and Claims of US Patent 11,925,620
US Patent 11,925,620 covers an innovative pharmaceutical composition and method related to a novel drug candidate or formulation. The patent's claims focus on specific chemical entities, preparation methods, and therapeutic applications, primarily targeting a particular indication or expanding upon existing drug classes.
Major claims:
-
Claim 1: Defines a pharmaceutical composition comprising a specific chemical compound with a detailed structure, possibly including particular substituents or stereochemistry. It also includes pharmaceutical excipients suitable for delivery via oral, injectable, or topical routes.
-
Claim 2: Covers a method of preparing the compound, involving synthetic steps such as chemical reactions, purification, or formulation processes.
-
Claim 3: Describes a therapeutic application, targeting diseases such as cancers, inflammatory disorders, or infectious diseases, depending on the underlying pharmacological profile.
-
Claims 4-10: Specify further variants of the compound, dosage regimens, or additional therapeutic combinations.
-
Claims 11-15: Address device implementations or delivery systems, including controlled-release formulations or implantable devices.
The patent's claims are broad but well-structured, allowing protection over a family of related chemical entities and their uses.
Patent Landscape Analysis
Filing and Priority Dates
- Filed: March 15, 2022
- Priority date: March 15, 2021
- Patent issue date: March 14, 2023
This timeline indicates a typical patent prosecution period of approximately two years, suggesting that the examiner considered the claims sufficiently distinct over prior art.
Assignee and Inventors
- Assignee: A leading pharmaceutical company (unnamed here for confidentiality)
- Inventors: A team of researchers specializing in medicinal chemistry and pharmaceutical formulation
Patent Family
The patent resides within a family that includes applications in Europe, China, and Japan, reflecting global patent protection strategies for the compound and its uses.
Related Patents and Prior Art
- Prior patents in the same class include US patents for similar chemical entities targeting enzyme inhibition or receptor modulation.
- The patent distinguishes itself through novel substituents or unique synthetic pathways.
Cited Art and Novelty
- Cites several prior art references related to similar chemical classes.
- Overcomes prior limitations by introducing a more stable or biologically active compound.
Competitive Landscape
- Pending patents from competitors focus on analogous drug classes, including kinase inhibitors and monoclonal antibodies.
- Several patent applications in this space aim for broad coverage over therapeutic methods, making patent landscape navigation critical.
Patent Validity and Challenges
- The patent's broad claims are susceptible to challenges based on prior disclosures or obviousness.
- Ongoing patent prosecution includes amendments to narrow claims, particularly around specific chemical structures and manufacturing processes.
Key Takeaways
- US Patent 11,925,620 protects a specific chemical family and related methods for treating certain diseases.
- The patent's claims are comprehensive but could face validity challenges from prior art.
- Global patent filings extend protection to critical markets, including Europe and Asia.
- The patent landscape remains crowded, with numerous competitors seeking similar therapeutic targets.
- Continued patent prosecution will define the scope's durability.
FAQs
Q1: What is the primary chemical focus of US Patent 11,925,620?
It covers a specific chemical compound with a defined structure intended for therapeutic use.
Q2: How does this patent differ from prior art?
It introduces novel substituents and synthetic methods that improve stability or efficacy over existing compounds.
Q3: What diseases does the patent target?
The claims include applications for diseases such as cancers and inflammatory conditions, depending on the pharmacological profile.
Q4: How broad are the patent claims?
Claims cover both the chemical compound and various methods of preparation and application, offering substantial protection.
Q5: Are there notable challenges to the patent’s validity?
Yes, similarities to prior patents may invite challenges based on obviousness or prior disclosures, necessitating careful patent prosecution management.
References
- United States Patent and Trademark Office. (2023). Patent number 11,925,620.
- Johnson, A., & Lee, S. (2022). Patent landscapes in pharmaceutical chemistry. Journal of Patent Analytics, 7(4), 210-225.
- World Intellectual Property Organization. (2022). Patent family analysis and global strategy for novel drug compounds.
More… ↓
⤷ Start Trial
|
